ArticleData in brief2020
Metagenomic 16S rDNA amplicon datasets from adolescents with normal weight, obesity, and obesity with irritable bowel syndrome from Eastern Siberia, Russia.
Article in Data in brief, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Meta-analysis of gut microbiota alterations in patients with irritable bowel syndrome.Frontiers in microbiology · 2024Pooled it
- Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.Microbiology spectrum · 2023Article
- Differences in Gut Microbiota Composition and Predicted Metabolic Functions: a Pilot Study of Adolescents with Normal Weight and Obesity.Bulletin of experimental biology and medicine · 2022Article
- Diversity and Metabolic Potential of the Gut Microbiome in Adolescents with Functional Bowel Disorder.Bulletin of experimental biology and medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Childhood obesity and its consequences are a significant public health problem worldwide. Gut microbiota has a potential role in the development of. In the current datasets, we present 16S rDNA amplicon metasequencing of the gut microbiome of adolescents with normal weight, obesity, and obesity with irritable bowel syndrome (IBS) carried out using the Illumine platform. The datasets presented in this report are partly shown in the research article named "Composition and Structure of Gut Microbiome in Adolescents with Obesity and Different Breastfeeding Duration" [1]. The amplicon metasequencing data were deposited at NCBI SRA as BioProject PRJNA604466. A total of 22 phyla, 34 classes, and 231 genera were revealed. Three groups of adolescents had 196 core amplicon sequence variant (ASV), whereas 45, 24, and 1 ASV were unique for adolescents with normal body weight, obesity, and obesity with IBS, respectively. The metagenomic data were first obtained for adolescents from Eastern Siberian, Russia. They have the potential for predictive analysis, which is crucial for understanding microbial community dynamics and their role in the development of the intestinal microbiome. Considering the recent focus on gut microbiota, new datasets are needed to determine the association between gut microbes and the weight of adolescents from previously unexplored regions such as Siberia, Russia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.